Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2022
“ Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis C Virus (HCV) Protease Inhibitor development. The report provides detailed cove ... Read More
-
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Epidemiology Forecast - 2032
DelveInsight's "" Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) epidemiology in the 7MM, i.e., the United State ... Read More
-
CAR T-cell Therapy - Pipeline Insight, 2022
“ CAR T-cell Therapy - Pipeline Insight, 2022 ” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics asses ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin"s lymphoma (NHL) - Epidemiology Forecast - 2032
DelveInsight's "" CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) epidemiology in the 7MM, i.e., the United States, EU5 (Germ ... Read More
-
Allogenic iNKT cell therapy - Epidemiology Forecast - 2032
DelveInsight's "" Allogenic iNKT cell therapy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Allogenic iNKT cell therapy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdo ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma - Epidemiology Forecast - 2032
DelveInsight's "" CAR T-Cell Therapy for Multiple Myeloma - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted CAR T-Cell Therapy for Multiple Myeloma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, Franc ... Read More
-
Spine Biologics/Orthobiologics - Market Insights, Competitive Landscape and Market Forecast-2026
Spine Biologics/Orthobiologics - Market Insights, Competitive Landscape and Market Forecast-2026 Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Bone Morphogenic Protein, Synthetic Bone Substitutes, Bone Grafts, Others), By Application (Osteoarthrit ... Read More
-
Bone Grafts and Substitutes - Market Insights, Competitive Landscape and Market Forecast–2026
Bone Grafts and Substitutes - Market Insights, Competitive Landscape and Market Forecast–2026 Bone Grafts and Substitutes Market By Source Type (Natural, Synthetic, And Others), By Product Type (Allografts [Demineralized Bone Matrix, Bone Morphogenetic Protein, And Cell-Based Matrices], Xenografts, ... Read More
-
Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast - 2032
DelveInsight's "" Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Limbal Stem Cells Deficiency (LSD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the ... Read More
-
Intravenous Immunoglobulin (IVIG) - Epidemiology Forecast - 2032
DelveInsight's "" Intravenous Immunoglobulin (IVIG) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Intravenous Immunoglobulin (IVIG) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
Antibody Drug Conjugate - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Antibody Drug Conjugate- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Antibody Drug Conjugate, historical and forecasted epidemiology as well as the Antibody Drug Conjugate market trends in the United States, EU5 (Germa ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2022
“ Anti-CD80 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022
“ Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline ... Read More
-
Exosomes - Pipeline Insight, 2022
“ Exosomes - Pipeline Insight, 2022 ” report provides comprehensive insights about 55+ companies and 70+ pipeline drugs in Exosomes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, ... Read More
-
Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032
DelveInsight's "" Hematopoietic Stem Cell Transplantation - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Hematopoietic Stem Cell Transplantation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, Franc ... Read More
-
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2022
“ Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Fatty Acid Amide Hydrolase (FAAH) Inhibitor development. The report provides detailed co ... Read More
-
Global Messenger RNA - Epidemiology Forecast - 2032
DelveInsight's "" Global Messenger RNA - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Global Messenger RNA epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2022
“ Anti-CD19 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape and Market Forecast-2026
Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape and Market Forecast-2026 Cardiac Biomarkers Testing Market By Product Type (Instruments And Reagents & Kits), By Biomarker Type (Troponin, Creatine Kinase-Mb, B-Type Natriuretic Peptide, Myoglobin, And Others]), By Applicat ... Read More
-
Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Gene And Cell Therapies In Rare Disorder- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Gene And Cell Therapies In Rare Disorder, historical and forecasted epidemiology as well as the Gene And Cell Therapies In Rare Diso ... Read More
-
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022
“ PD-1 and PD-L1 inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in PD-1 and PD-L1 inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Epidemiology Forecast - 2032
DelveInsight's "" Alpha-1 Protease Inhibitor Deficiency - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Alpha-1 Protease Inhibitor Deficiency epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, a ... Read More
-
Gene Therapy for Ocular Rare Disease - Epidemiology Forecast - 2032
DelveInsight's "" Gene Therapy for Ocular Rare Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Gene Therapy for Ocular Rare Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Androgen Insensitivity Syndrome - Epidemiology Forecast - 2032
DelveInsight's "" Androgen Insensitivity Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Androgen Insensitivity Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022
“ Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More
Research Assistance
